Aptevo Therapeutics Inc. (APVO) vs Evogene Ltd. (EVGN)
A side-by-side comparison of Aptevo Therapeutics Inc. and Evogene Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
EVGN
Evogene Ltd.
$0.42HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — APVO vs EVGN
growth of $100 · dividends reinvested · last 10yAPVO -100.0% (-80.3%/yr)EVGN -99.4% (-39.7%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
APVO EVGN
APVO vs EVGN: by the numbers
- •APVO is the larger company ($4M vs $4M market cap).
- •Both run net losses; APVO's is the smaller (0.00% vs -694.19% net margin).
Metrics side by side
Valuation
| Metric | APVO | EVGN |
|---|---|---|
| P/S ratio | N/A | 2.79 |
| P/B ratio | 0.65 | N/A |
Profitability
| Metric | APVO | EVGN |
|---|---|---|
| Gross margin | 0.00% | -6.25% |
| Operating margin | 0.00% | -364.24% |
| Net margin | 0.00% | -694.19% |
| ROE | -437.15% | N/A |
| ROIC | -288.14% | -130.12% |
Growth (annualized)
| Metric | APVO | EVGN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 2.86% |
| Total return CAGR (5Y) | -95.30% | -56.46% |
Frequently asked
- How have APVO and EVGN total returns compared?
- Over the past 10 years, APVO delivered -80.35% and EVGN delivered -39.70% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.